The transcription profiles associated with TRIM66 expression were significantly depleted, with stem cell markers in 23 tumor types and the normalized enrichment score ranging from −7.01 (LUAD) to −3.07 (PRAD) (Figure 5D). This evidence concerns the gene TRIM66 and neoplasm.